UBS Group’s Diebold Nixdorf DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
MCM
VCM
BPCM
UBS Group's DBD Position: Q1 2026 in Review
UBS Group reduced its Diebold Nixdorf (DBD) stake by 6.6% in Q1 2026, selling an estimated $469K and leaving 90,629 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3746.
UBS Group first reported a position in DBD in Q3 2023 and has held it in 10 quarters since. The position peaked at $7.9M in Q3 2025. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.
- UBS Group held 90,629 shares of Diebold Nixdorf worth $6.84M as of Q1 2026.
- UBS Group sold 6,376 Diebold Nixdorf shares in Q1 2026, an estimated $469K.
- Diebold Nixdorf made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3746 holding.
- UBS Group first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 10 quarters since.
- UBS Group's Diebold Nixdorf position peaked at $7.9M in Q3 2025.
- 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.